Core Laboratories N.V. (CLB) Reports In-Line Q2 EPS, Updates Guidance
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $11.64 -1.1%
EPS Growth %: +36.4%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +36.4%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Core Laboratories N.V. (NYSE: CLB) reported Q2 EPS of $1.32, in-line with the analyst estimate of $1.32. Revenue for the quarter came in at $263.1 million versus the consensus estimate of $267.24 million.
Core Laboratories N.V. sees Q3 2013 EPS of $1.33-1.34, versus the consensus of $1.34. Core Laboratories N.V. sees Q3 2013 revenue of $263-268 million, versus the consensus of $270.38 million.
Core Laboratories N.V. sees Q4 2013 EPS of $1.37-1.38, versus the consensus of $1.38. Core Laboratories N.V. sees Q4 2013 revenue of $268-270 million.
For earnings history and earnings-related data on Core Laboratories N.V. (CLB) click here.
Core Laboratories N.V. sees Q3 2013 EPS of $1.33-1.34, versus the consensus of $1.34. Core Laboratories N.V. sees Q3 2013 revenue of $263-268 million, versus the consensus of $270.38 million.
Core Laboratories N.V. sees Q4 2013 EPS of $1.37-1.38, versus the consensus of $1.38. Core Laboratories N.V. sees Q4 2013 revenue of $268-270 million.
For earnings history and earnings-related data on Core Laboratories N.V. (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- After-Hours Stock Movers: FDX, CBRS, NKE
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
